Dr Kimberly Maxfield Highlights FDA’s Education Efforts to Increase Biosimilar Comfort

Kimberly Maxfield, PhD, of the FDA reflected upon how the FDA is uplifting the US biosimilar industry.Kimberly Maxfield, PhD, of the FDA explained how the FDA is uplifting the US biosimilar industry. Maxfield expanded upon the biosimilars topic during the AMCP Nexus session, “Biosimilar Operational Readiness: Marketplace Trends and Regulatory Considerations” on October 17.At the […]